FEV1 % predicted: absolute change from baseline · adults with CFRD
Summary of findings: insulin showed no clear difference in FEV1 % predicted: change from baseline compared with placebo (low certainty).
1 finding from 1 review
Hypoglycemia mean number of events per participant · adults with CFRD and fasting hyperglycemia
It is very uncertain whether summary of findings: NPH insulin changes hypoglycemia mean number of events per participant compared with glargine (very low certainty).
1 finding from 1 review
FVC (% predicted) Change from baseline · adults with CFRD
Summary of findings: insulin showed no clear difference in FVC % predicted: change from baseline compared with placebo (low certainty).
1 finding from 1 review
Change in BMI · adults with CFRD
Summary of findings: insulin showed no clear difference in BMI(kg/m²): change from baseline compared with placebo (low certainty).
1 finding from 1 review
Hypoglycemia: number of episodes · adults with CFRD
Summary of findings: insulin showed no clear difference in hypoglycemia: number of episodes compared with placebo (low certainty).
1 finding from 1 review
HbA1c (%) · adults with CFRD
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adults with CFRD
Summary of findings: repaglinide showed no clear difference in FEV1 % predicted; change from baseline compared with placebo (low certainty).
1 finding from 1 review
FVC (% predicted) Change from baseline · adults with CFRD
Summary of findings: repaglinide showed no clear difference in FVC % predicted: change from baseline compared with placebo (low certainty).
1 finding from 1 review
Change in BMI · adults with CFRD
Summary of findings: repaglinide showed no clear difference in BMI (kg/m²): change from baseline compared with placebo (low certainty).
1 finding from 1 review
Change in disability score · children with SMA types II and III
1 finding from 1 review
Acquiring ability to walk · adults with SMA types II and III
1 finding from 1 review
Change in quality of life · adults with SMA types II and III
1 finding from 1 review
Change in pulmonary function · adults with SMA types II and III
1 finding from 1 review
Change in disability score · children and adults with SMA types II and III
2 findings from 1 review
Muscle strength · children and adults with SMA types II and III
1 finding from 1 review
Acquiring the ability to stand or walk · children and adults with SMA types II and III
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in quality of life · children and adults with SMA types II and III
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Muscle strength · children with SMA types II and III
1 finding from 1 review
Change in pulmonary function · children and adults with SMA types II and III
1 finding from 1 review
Change in disability score · children with SMA type II
Intrathecal injected nusinersen probably leads to higher change in disability score compared with sham procedure (moderate certainty).
1 finding from 1 review